M

MyoPax

3 employees

MyoPax creates advanced regenerative stem cell therapies to combat the devasting effects of muscle illnesses.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Muscular dystrophies
Rare diseases
Gene Editing
Muscle diseases
Health Care
Muscle regeneration
Muscle Stem Cells

Date founded

2022

Funding rounds raised

Total raised

$1.3M

from 1 investors over 1 rounds

M

MyoPax raised $1.3M on August 21, 2022

Investors: BioInnovation Institute

FAQ